Alyeska Investment Group, L.P.

Position in NVO — Novo Nordisk A S

CIK 1453072 CHICAGO, IL

Position in NVO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$355,887

-$17,696,786 QoQ

Shares Held

9,684

-95.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $1,016,752,962 across 7 Drug Manufacturers - General names. NVO ranks #7 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	2,305,574	$277,337,496
2	AZN	Astrazeneca PLC	1,062,278	$209,502,467
3	JNJ	Johnson & Johnson	834,692	$204,032,112
4	BIIB	Biogen Inc.	805,050	$147,589,816
5	SNY	Sanofi	2,306,229	$111,114,113
6	GSK	GSK plc	1,210,746	$66,821,071
7	NVO	Novo Nordisk A S This page	9,684	$355,887

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$355,887	9,684	-95.4%	Shares	Sole	2026-05-15
2024-12-31	$18,052,673	209,866	-74.3%	Shares	Sole	2025-02-14
2024-09-30	$97,385,566	817,885	+218.3%	Shares	Sole	2024-11-14
2024-06-30	$36,683,038	256,992	-33.8%	Shares	Sole	2024-08-14
2022-12-31	$26,262,050	388,090	-17.0%	Shares	Sole	2023-02-14
2022-09-30	$23,303,905	467,809	-52.5%	Shares	Sole	2022-11-14
2022-06-30	$54,820,941	983,953	+9.3%	Shares	Sole	2022-08-15
2022-03-31	$49,997,819	900,456	+93.4%	Shares	Sole	2022-05-17
2021-12-31	$26,074,440	465,615	+0.3%	Shares	Sole	2022-02-14
2021-09-30	$22,275,472	464,024	+153.5%	Shares	Sole	2021-11-15
2021-06-30	$7,667,426	183,059	-56.9%	Shares	Sole	2021-08-16
2021-03-31	$14,326,750	425,000	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.